Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 November 2022 | Story Edzani Nephalela and Dr Nomalungelo Ngubane | Photo iStock
Language
The UFS and UKZN have formalised an agreement on a Language Collaboration Memorandum of Understanding (MOU) to advance the development of the Sesotho and IsiZulu as academic languages.

The University of the Free State (UFS) has forged an exciting new partnership with the University of KwaZulu-Natal (UKZN) to promote the two provinces’ most widely spoken languages, Sesotho and IsiZulu.  

This historic collaboration will see these institutions employing their skills, expertise, and resources to advance the development of the Sesotho and IsiZulu as academic languages through the development of terminology for various disciplines and research collaborations among other activities. 

The UFS formalised the agreement by signing a Language Collaboration Memorandum of Understanding (MOU) with UKZN. The MOU process, facilitated by Dr Nomalungelo Ngubane, Director of the UFS Academy for Multilingualism, and Nikile Ntsababa, UFS Registrar, was sealed by Dr Engela Van Staden, UFS Vice-Rector: Academic. 

The objectives of the collaboration are to: 

• allow the UFS open access to all the UKZN isiZulu materials and UKZN open access to all UFS Sesotho language terminology, corpus materials, terminology banks, and applications for various disciplines; 
• develop the Sesotho terminology for various disciplines;
• assist in identifying and closing any gaps in the UFS’s development of isiZulu terminology and in the UKZN’s development of isiZulu, and further develop the relevant language terminology of various disciplines in order to fill any existing gaps;
• share expertise through hosting webinars, seminars, colloquia, and workshops on Sesotho and isiZulu terminology development;
• explore research opportunities regarding the development of Sesotho and isiZulu terminology for various disciplines; and 
• share expertise and resources in all human language technology development initiatives.

“The UKZN has championed the intellectualisation of IsiZulu over the years. We do not want to reinvent the wheel,” Dr Ngubane said. “Our focus now is on the acceleration of the development of Sesotho. Our vision and mission is to be the hub for the advancement of Sesotho at regional, national, and international levels. Collaboration with UKZN is instrumental in achieving this mandate.”

The Academy for Multilingualism said it considers this collaboration historic and groundbreaking because resources will now be invested in the development of Sesotho.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept